Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haematobium infection

American Journal of Tropical Medicine and Hygiene

Volumn 66, Issue 6, 2002, Pages 725-730

  King, Charles H ^a   Muchiri, Eric M ^a   Mungai, Peter ^a   Ouma, John H ^a   Kadzo, Hilda ^a   Magak, Philip ^a   Koech, Davy K ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; FEMALE; HEMATURIA; HUMAN; INFANT; KENYA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHUMAN; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; TREMATODA;

EID: 0036592652     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.66.725     Document Type: Article

References (26)

1. Disease in schistosomiasis haematobia
2. The pathobiology of Schistosoma haematobium infection in humans
3. Single dose metrifonate or praziquantel treatment in Kenyan children. II. Effects on growth in relation to Schistosoma haemaiobium and hookworm egg counts
4. Single dose metrifonate or praziquantel treatment in Kenyan children. I. Effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly
5. Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis
6. Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia
7. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium
8. Dosefinding study for praziquantel therapy of Schistosoma haematobium in Coast Province, Kenya
9. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel
10. Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya
11. Double-blind placebo controlled study of concurrent administration of albendazole and praziquantel in school children with schistosomiasis and geohelminths
12. Epidemiology
13. Urinary tract morbidity in schistosomiasis haematobia: Associations with age and intensity of infection in an endemic area of Coast Province, Kenya
14. Dynamics and control of Schistosoma haematobium transmission in Kenya: An overview of the Msambweni Project
15. Ultrasonographic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel
16. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity
17. Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples
18. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection
19. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations
20. Praziquantel
21. Drugs for parasitic infections
22. Praziquantel and the control of schistosomiasis
23. Drug-resistant schistosomiasis: Resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific
24. An international initiative on praziquantel use
25. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya
26. Praziquantel - Its use, cost and possible development of resistance